Mescolini Giulia, Baigent Susan J, Catelli Elena, Nair Venugopal K
Avian Pathology Service, Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Viral Oncogenesis Group, The Pirbright Institute, Woking, United Kingdom.
Front Vet Sci. 2022 Jun 23;9:873163. doi: 10.3389/fvets.2022.873163. eCollection 2022.
Marek's disease, an economically important disease of chickens caused by virulent serotype 1 strains of the Marek's disease virus (MDV-1), is effectively controlled in the field by live attenuated vaccine viruses including herpesvirus of turkeys (HVT)-both conventional HVT (strain FC126) and, in recent years, recombinant HVT viruses carrying foreign genes from other avian viruses to protect against both Marek's disease and other avian viral diseases. Testing to monitor and confirm successful vaccination is important, but any such test must differentiate HVT from MDV-1 and MDV-2, as vaccination does not prevent infection with these serotypes. End-point and real-time PCR tests are widely used to detect and differentiate HVT, MDV-1 and MDV-2 but require expensive specialist laboratory equipment and trained operators. Here, we developed and validated two tube-based loop-mediated isothermal amplification tests coupled with detection by lateral flow device readout (LAMP-LFD): an HVT-specific test to detect both conventional and recombinant HVT strains, and a second test using novel LAMP primers to specifically detect the Vaxxitek® recombinant HVT. Specificity was confirmed using DNA extracted from virus-infected cultured cells, and limit of detection was determined using plasmid DNA carrying either the HVT or Vaxxitek® genome. The LAMP-LFD tests accurately detected all HVT vaccines, or Vaxxitek® only, in crude DNA as well as purified DNA extracted from field samples of organs, feathers, or poultry house dust that were confirmed positive for HVT by real-time PCR. These LAMP-LFD tests have potential for specific, rapid, simple, and inexpensive detection of HVT vaccines in the field.
马立克氏病是由1型强毒株马立克氏病病毒(MDV - 1)引起的一种对养鸡业具有重要经济影响的疾病。在实际生产中,可通过活的减毒疫苗病毒有效控制该病,这些疫苗病毒包括火鸡疱疹病毒(HVT)——传统的HVT(FC126株),以及近年来携带来自其他禽病毒的外源基因的重组HVT病毒,以预防马立克氏病和其他禽病毒性疾病。监测和确认疫苗接种成功的检测很重要,但任何此类检测都必须区分HVT与MDV - 1和MDV - 2,因为接种疫苗并不能预防这些血清型的感染。终点PCR和实时PCR检测被广泛用于检测和区分HVT、MDV - 1和MDV - 2,但需要昂贵的专业实验室设备和经过培训的操作人员。在此,我们开发并验证了两种基于试管的环介导等温扩增检测方法,并结合侧向流动装置读数进行检测(LAMP - LFD):一种是HVT特异性检测方法,用于检测传统和重组HVT毒株;另一种检测方法使用新型LAMP引物特异性检测Vaxxitek®重组HVT。使用从病毒感染的培养细胞中提取的DNA确认了特异性,并使用携带HVT或Vaxxitek®基因组的质粒DNA确定了检测限。LAMP - LFD检测方法能够准确检测粗DNA以及从器官、羽毛或禽舍灰尘的现场样本中提取的纯化DNA中的所有HVT疫苗或仅Vaxxitek®,这些样本经实时PCR确认为HVT阳性。这些LAMP - LFD检测方法具有在现场特异性、快速、简单且廉价地检测HVT疫苗的潜力。